Membrane interactive α-helices in GPCRs as a novel drug target

被引:21
作者
Nemoto, Wataru [1 ]
Toh, Hiroyuki
机构
[1] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 6110011, Japan
[2] NAIST, Grad Sch Informat Sci, Nara 6300101, Japan
[3] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan
关键词
G-protein coupled receptors; oligomerization; transmembrane alpha-helices; protein-protein interaction (PPI); signal transduction; interface prediction; bioinformatics;
D O I
10.2174/138920306779025657
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G-Protein Coupled Receptors (GPCRs) are one of the most important targets for pharmaceutical drug design. Over the past 30 years, mounting evidence has suggested the existence of homo and hetero dimers or higher-order complexes (oligomers) that are involved in signal transduction and some diseases. The number of reports describing GPCR oligomerization has increased, and in 2003, the organization of mouse rhodopsin into two-dimensional arrays of dimers was determined by an atomic force microscopic analysis. The analysis of the mouse rhodopsin complex has enabled us to discuss the oligomerization based on structural data. Although many unsolved problems still remains, the idea that GPCRs directly interact to form oligomers has been gradually accepted. One of the recent findings in the GPCR investigations is the clarification of the mechanisms of GPCR oligomerization at a molecular level. Most of these studies have suggested the importance of transmembrane alpha-helices for GPCR oligomerization. In this review, we will first summarize the importance of GPCR oligomerization and the functions of GPCRs. Then, we will explain the involvement of transmembrane. alpha-helices in the oligomerization and a drug design strategy that targets these regions for GPCR oligomerization. Considering the current drug design methods, which are based on the modification of the protein-protein interactions of soluble regions of proteins, a "peptide mimic approach" that targets the transmembrane alpha-helices constituting the interfaces would be promising in drug discovery for GPCR oligomerization. For that purpose, we must know the positions of the interfaces. However, problems specific to membrane proteins have made it difficult to identify the positions of the interfaces experimentally. Therefore, information about the interfaces predicted by bioinformatics approaches is valuable. At the end of this review, several bioinformatics approaches toward interface prediction for oligomerization are introduced. The benefits and the pitfalls of these approaches are also discussed.
引用
收藏
页码:561 / 575
页数:15
相关论文
共 140 条
  • [71] Oligomerization of opioid receptors with β2-adrenergic receptors:: A role in trafficking and mitogen-activated protein kinase activation
    Jordan, BA
    Trapaidze, N
    Gomes, I
    Nivarthi, R
    Devi, LA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) : 343 - 348
  • [72] The dopamine D3 receptor interacts with itself and the truncated D3 splice variant D3nf: D3-D3nf interaction causes mislocalization of D3 receptors
    Karpa, KD
    Lin, RW
    Kabbani, N
    Levenson, R
    [J]. MOLECULAR PHARMACOLOGY, 2000, 58 (04) : 677 - 683
  • [73] GABAB-receptor subtypes assemble into functional heteromeric complexes
    Kaupmann, K
    Malitschek, B
    Schuler, V
    Heid, J
    Froest, W
    Beck, P
    Mosbacher, J
    Bischoff, S
    Kulik, A
    Shigemoto, R
    Karschin, A
    Bettler, B
    [J]. NATURE, 1998, 396 (6712) : 683 - 687
  • [74] C5a receptor oligomerization - I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor
    Klco, JM
    Lassere, TB
    Baranski, TJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) : 35345 - 35353
  • [75] KOSHI JM, 1995, PROTEIN ENG, V8, P641
  • [76] G-protein coupled receptor oligomerization in neuroendocrine pathways
    Kroeger, KM
    Pfleger, KDG
    Eidne, KA
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 2003, 24 (04) : 254 - 278
  • [77] Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor - Detection in living cells using bioluminescence resonance energy transfer
    Kroeger, KM
    Hanyaloglu, AC
    Seeber, RM
    Miles, LEC
    Eidne, KA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) : 12736 - 12743
  • [78] Role of heteromer formation in GABAB receptor function
    Kuner, R
    Köhr, G
    Grünewald, S
    Eisenhardt, G
    Bach, A
    Kornau, HC
    [J]. SCIENCE, 1999, 283 (5398) : 74 - 77
  • [79] Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
    Kunishima, N
    Shimada, Y
    Tsuji, Y
    Sato, T
    Yamamoto, M
    Kumasaka, T
    Nakanishi, S
    Jingami, H
    Morikawa, K
    [J]. NATURE, 2000, 407 (6807) : 971 - 977
  • [80] Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell
    Lee, SP
    O'Dowd, BF
    Ng, GYK
    Varghese, G
    Akil, H
    Mansour, A
    Nguyen, T
    George, SR
    [J]. MOLECULAR PHARMACOLOGY, 2000, 58 (01) : 120 - 128